Publications by authors named "Todd Sherer"

Claim this Profile
A
A community-led initiative to de-risk and advance Parkinson's disease therapeutic targets.
Alexandra Vaiana, Jonathan Behr, Ryan Birol, Cornelis Blauwendraat, Bradford Casey, Todd Sherer

NPJ Parkinsons Dis· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of dopamine deficiency and REM sleep behavior disorder on cognition in early neuronal synuclein disease with hyposmia.
Daniel Weintraub, Anuprita R Nair, Ryan Kurth, Michael C Brumm, Michele K York, Todd Sherer

medRxiv· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neuronal alpha-Synuclein Disease Integrated Staging System performance in PPMI, PASADENA, and SPARK baseline cohorts.
Tien Dam, Gennaro Pagano, Michael C Brumm, Caroline Gochanour, Kathleen L Poston, Todd Sherer

medRxiv· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neuronal alpha-Synuclein Disease integrated staging system performance in PPMI, PASADENA, and SPARK baseline cohorts.
Tien Dam, Gennaro Pagano, Michael C Brumm, Caroline Gochanour, Kathleen L Poston, Todd Sherer

NPJ Parkinsons Dis· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A biological definition of neuronal α-synuclein disease: towards an integrated staging system for research.
Tanya Simuni, Lana M Chahine, Kathleen Poston, Michael Brumm, Teresa Buracchio, Todd Sherer

Lancet Neurol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Challenges and Opportunities for Commercializing Technologies in the Pulmonary Arena: An Official American Thoracic Society Report.
Milica Vukmirovic, Kambez H Benam, Jason J Rose, Scott Turner, Chelsea M Magin, Todd Sherer

Ann Am Thorac Soc· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of heterogeneity among participants in the Parkinson's Progression Markers Initiative cohort using α-synuclein seed amplification: a cross-sectional study.
Andrew Siderowf, Luis Concha-Marambio, David-Erick Lafontant, Carly M Farris, Yihua Ma, Todd Sherer

Lancet Neurol· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proposal for a Biologic Staging System of Parkinson's Disease.
Lana M Chahine, Kalpana Merchant, Andrew Siderowf, Todd Sherer, Caroline Tanner

J Parkinsons Dis· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
LRRK2 and GBA1 variant carriers have higher urinary bis(monacylglycerol) phosphate concentrations in PPMI cohorts.
Kalpana M Merchant, Tanya Simuni, Janel Fedler, Chelsea Caspell-Garcia, Michael Brumm, Todd Sherer

NPJ Parkinsons Dis· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Precision medicine for Parkinson's disease: The subtyping challenge.
Mark Frasier, Brian K Fiske, Todd B Sherer

Front Aging Neurosci· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Longitudinal clinical and biomarker characteristics of non-manifesting LRRK2 G2019S carriers in the PPMI cohort.
Tanya Simuni, Kalpana Merchant, Michael C Brumm, Hyunkeun Cho, Chelsea Caspell-Garcia, Todd Sherer

NPJ Parkinsons Dis· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Six Action Steps to Address Global Disparities in Parkinson Disease: A World Health Organization Priority.
Nicoline Schiess, Rodrigo Cataldi, Michael S Okun, Natasha Fothergill-Misbah, E Ray Dorsey, Todd Sherer

JAMA Neurol· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Forecasts for the Attainment of Major Research Milestones in Parkinson's Disease.
Patrick Bodilly Kane, Daniel M Benjamin, Roger A Barker, Anthony E Lang, Todd Sherer

J Parkinsons Dis· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Data Sharing Goals for Nonprofit Funders of Clinical Trials.
Timothy Coetzee, Mad Price Ball, Marc Boutin, Abby Bronson, David T Dexter, Todd Sherer

J Particip Med· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Data Sharing Goals for Nonprofit Funders of Clinical Trials.
Timothy Coetzee, Mad Price Ball, Marc Boutin, Abby Bronson, David T Dexter, Todd Sherer

J Particip Med· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of Patient and Expert Perceptions of the Attainment of Research Milestones in Parkinson's Disease.
Patrick Bodilly Kane, Daniel M Benjamin, Roger A Barker, Anthony E Lang, Todd Sherer

Mov Disord· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
LRRK2 inhibitors induce reversible changes in nonhuman primate lungs without measurable pulmonary deficits.
Marco A S Baptista, Kalpana Merchant, Ted Barrett, Sakshi Bhargava, Dianne K Bryce, Todd B Sherer

Sci Transl Med· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disease modification and biomarker development in Parkinson disease: Revision or reconstruction?
Alberto J Espay, Lorraine V Kalia, Ziv Gan-Or, Caroline H Williams-Gray, Philippe L Bedard, Todd Sherer

Neurology· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Emerging Evidence of the Parkinson Pandemic.
E Ray Dorsey, Todd Sherer, Michael S Okun, Bastiaan R Bloem

J Parkinsons Dis· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Feasibility and safety of lumbar puncture in the Parkinson's disease research participants: Parkinson's Progression Marker Initiative (PPMI).
Neha Prakash, Chelsea Caspell-Garcia, Christopher Coffey, Andrew Siderowf, Caroline M Tanner, Todd Sherer

Parkinsonism Relat Disord· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Revisiting protein aggregation as pathogenic in sporadic Parkinson and Alzheimer diseases.
Alberto J Espay, Joaquin A Vizcarra, Luca Marsili, Anthony E Lang, David K Simon, Todd Sherer

Neurology· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Parkinson's progression markers initiative (PPMI) - establishing a PD biomarker cohort.
Kenneth Marek, Sohini Chowdhury, Andrew Siderowf, Shirley Lasch, Christopher S Coffey, Todd Sherer

Ann Clin Transl Neurol· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Finding useful biomarkers for Parkinson's disease.
Alice S Chen-Plotkin, Roger Albin, Roy Alcalay, Debra Babcock, Vikram Bajaj, Todd Sherer

Sci Transl Med· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Longitudinal Change of Clinical and Biological Measures in Early Parkinson's Disease: Parkinson's Progression Markers Initiative Cohort.
Tanya Simuni, Andrew Siderowf, Shirley Lasch, Chris S Coffey, Chelsea Caspell-Garcia, Todd Sherer

Mov Disord· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is Axonal Degeneration a Key Early Event in Parkinson's Disease?
Zuzanna Kurowska, Jeffrey H Kordower, A Jon Stoessl, Robert E Burke, Patrik Brundin, Todd B Sherer

J Parkinsons Dis· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis